52
2
0
Like?
Please wait...
About This Project
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.
Browse Other Projects on Experiment
Related Projects
Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection
We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...
The Dogs of Chernobyl Research Initiative
The Chernobyl disaster site has hundreds of feral dogs that are in need of care. A team of students from...
Which Human Physical Aging Biomarkers Validate Genetic and Biochemical Aging Reversal Success?
Harvard Medical School has reported successful aging reversal using genetic and biochemical methods in the...